Thus, the changes in JIP3 and JIP4 localisation we observed in prostate tumours may cause alterations to cell surface delivery and recycling pathways, which can in turn affect cargo delivery, such as the metalloproteinase MMP14 that are used to degrade extracellular matrix [25]. The gene discussed is SPAG9; the disease is prostate neoplasm.